CATALOGO DEI PRODOTTI DELLA RICERCA

CRISAFULLI, Ernesto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.586
AS - Asia 2.368
EU - Europa 2.255
SA - Sud America 423
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 6
Totale 8.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.535
SG - Singapore 1.085
IT - Italia 657
CN - Cina 502
HK - Hong Kong 417
BR - Brasile 363
FR - Francia 350
RU - Federazione Russa 309
IE - Irlanda 303
DE - Germania 212
KR - Corea 125
SE - Svezia 120
VN - Vietnam 92
NL - Olanda 72
FI - Finlandia 68
GB - Regno Unito 65
AR - Argentina 26
IN - India 26
CA - Canada 25
BD - Bangladesh 21
BE - Belgio 20
ID - Indonesia 18
TR - Turchia 16
PL - Polonia 15
JP - Giappone 14
IQ - Iraq 13
MX - Messico 12
AT - Austria 10
EU - Europa 10
TG - Togo 10
UA - Ucraina 10
EC - Ecuador 9
CL - Cile 8
ES - Italia 8
LT - Lituania 7
CO - Colombia 6
UZ - Uzbekistan 6
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
KE - Kenya 4
LB - Libano 4
LV - Lettonia 4
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
IR - Iran 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
PK - Pakistan 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
NC - Nuova Caledonia 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.680
Salva come PNG Salva come JPEG
Città #
Dallas 1.214
Chandler 476
Singapore 451
Hong Kong 416
Dublin 298
Jacksonville 184
Ashburn 129
Lawrence 108
Princeton 108
Sindelfingen 100
Seattle 85
Wilmington 84
Beijing 73
The Dalles 69
Verona 66
Los Angeles 59
New York 55
Redondo Beach 53
Rome 44
Buffalo 43
Columbus 43
Munich 39
Boardman 38
Ho Chi Minh City 36
Milan 36
Redmond 35
Helsinki 33
São Paulo 27
Ann Arbor 25
Bologna 25
Turku 25
Southend 24
Norwalk 23
Frankfurt am Main 18
Council Bluffs 17
Nuremberg 17
Santa Clara 17
Brussels 16
Dongguan 16
Hanoi 14
Jinan 14
Tianjin 13
Chicago 12
Falls Church 12
Guangzhou 12
Tokyo 12
Amsterdam 11
Kent 11
London 11
Rio de Janeiro 11
San Francisco 11
Warsaw 11
Lappeenranta 10
Lomé 10
Nanjing 10
Mexico City 9
Trento 9
Curitiba 8
Fairfield 8
Hangzhou 8
Jakarta 8
Toronto 8
Turin 8
Cesena 7
Changsha 7
Haiphong 7
Hebei 7
Nanchang 7
Seoul 7
Taiyuan 7
Vienna 7
Villarbasse 7
Zhengzhou 7
Ankara 6
Belo Horizonte 6
Boston 6
Brooklyn 6
City of Westminster 6
Falkenstein 6
Fortaleza 6
Haikou 6
Jiaxing 6
New Delhi 6
Ningbo 6
Parma 6
Pavia 6
Reggio Emilia 6
Shenyang 6
Washington 6
Xi'an 6
Baghdad 5
Bari 5
Como 5
Genoa 5
Meda 5
Montreal 5
Ottawa 5
Paris 5
Ribeirão Preto 5
Salvador 5
Totale 5.098
Salva come PNG Salva come JPEG
Nome #
Polmonite interstiziale con caratteristiche autoimmuni (IPAF) Interstitial pneumonia with autoimmune features (IPAF 549
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice 281
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 245
Role of Non-Invasive Ventilation in Elderly Patients: Therapeutic Opportunity or Medical Futility? An Updated Narrative Review 236
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 119
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 114
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 110
Nervous system: subclinical target of SARS-CoV-2 infection 103
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 102
Six-minute walk distance in healthy subjects: reference standards from a general population sample 101
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 100
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 99
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 99
Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case 97
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 91
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 90
Short-term efficacy of upper-extremity exercise training in patients with chronic airway obstruction: A systematic review 86
C-reactive protein at discharge, diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease 84
Impact of sex on circulating leukocytes composition in COPD patients 83
Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD 82
Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial 79
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 79
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 78
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 76
Are interstitial lung abnormalities associated with COPD? A nested case–control study 75
A High Degree of Dyspnea Is Associated With a Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction 73
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 73
Feasibility and effectiveness of an educational program in Italian COPD patients undergoing rehabilitation 72
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 72
Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study 70
Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation 70
Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors 70
Assessment of severity of ICU-acquired pneumonia and association with etiology 69
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 69
The Caliber of Segmental and Subsegmental Vessels in COVID-19 Pneumonia Is Enlarged: A Distinctive Feature in Comparison with Other Forms of Inflammatory and Thromboembolic Diseases 68
Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients 68
Endotracheal tubes for critically ill patients: An in vivo analysis of associated tracheal injury , mucociliary clearance, and sealing effi cacy 67
A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD 67
Activity and analysis of costs in a dedicated weaning centre 66
Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients 66
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 65
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 65
Acute exacerbations of COPD: Risk factors for failure and relapse 64
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 63
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 63
Efficacy of standard rehabilitation in COPD outpatients with comorbidities 63
COPD and the metabolic syndrome: An intriguing association 63
Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients 62
Cost-effectiveness of NIV applied to chronic respiratory failure 59
Long-term weight loss and maintenance in morbidly obese individuals with obstructive sleep apnea 59
Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls 57
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 57
Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation 56
Respiratory muscles training in COPD patients 56
Management of severe acute exacerbations of COPD: an updated narrative review 55
COPD 2017: A Year in Review 55
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study 54
Pleuritis with pleural effusion due to a Bacillus megaterium infection 53
Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: Comparison of costs 53
Rehabilitation and supportive therapy in elderly patients with chronic obstructive pulmonary disease 53
Learning impact of education during pulmonary rehabilitation program. An observational short-term cohort study 53
Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study 52
Home-centred physical fitness programme in morbidly obese individuals: A randomized controlled trial 52
Cough, a vital reflex. mechanisms, determinants and measurements 52
Predicting poor prognosis in COPD patients: Looking for a lamp lit in the darkness of the night 52
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease 52
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 52
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry 51
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis 51
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma 51
Readmission in COPD patients: Should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?: To the editor 51
The role of the microbiome in childhood asthma 51
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization 50
Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD 50
Co-morbidities in chronic respiratory patients: limitations or opportunities for caring? 50
Energy expenditure at rest and during walking in patients with chronic respiratory failure: a prospective two-phase case-control study 50
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 50
Subjective sleep quality during average volume assured pressure support (AVAPS) ventilation in patients with hypercapnic COPD: A physiological pilot study 49
Rehabilitation in COPD patients admitted for exacerbation 49
Predicting walking-induced oxygen desaturations in COPD patients: A statistical model 49
Erratum: Subjective sleep quality during Average Volume Assured Pressure Support (AVAPS) ventilation in patients with hypercapnic COPD: A physiological pilot study (Lung (2009) 187: 5 (299-305) DOI: 10.1007/s00408-009-9167-1) 49
Predictors of Readmission in a Period of 30 Days or Less in Acute Exacerbation of Chronic Obstructive Pulmonary Disease 47
Do we now have a couch potato blood test? 47
Raccomandazioni Italiane sulla Pneumologia Riabilitativa. Evidenze scientifiche e messaggi clinico-pratici 46
Diagnosis of Chronic Obstructive Pulmonary Disease, simpler is better Complexity and simplicity 46
Effects of early inpatient rehabilitation after acute exacerbation of COPD 45
Effects of a walking aid in COPD patients receiving oxygen therapy 45
Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients 45
Series "novelties in pulmonary rehabilitation": Determinants of success 45
Early rehabilitation: Much better than nothing 45
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 44
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 44
Innate immune reprogramming in circulating neutrophils of COPD patients 44
Next generation beta adrenoreceptor agonists for the treatment of asthma 44
Heart rate recovery is associated with ventilatory constraints and excess ventilation during exercise in patients with chronic obstructive pulmonary disease 44
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 44
Measures of dyspnea in pulmonary rehabilitation 43
Pneumonic and nonpneumonic exacerbations of COPD: Inflammatory response and clinical characteristics 43
Respiratory muscle training in patients recovering recent open cardiothoracic surgery: A randomized-controlled trial 42
Predicting In-Hospital Treatment Failure (<= 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids 41
Totale 7.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.091
article - articoli 39.867
book - libri 0
conference - conferenze 319
curatela - curatele 0
other - altro 129
patent - brevetti 0
selected - selezionate 0
volume - volumi 776
Totale 82.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021468 0 0 0 12 211 100 6 4 15 10 93 17
2021/2022581 18 142 4 22 13 20 6 74 30 26 88 138
2022/20231.583 132 115 230 246 130 380 12 104 140 21 42 31
2023/20241.002 47 73 139 141 63 126 48 92 10 40 127 96
2024/20252.767 196 103 79 420 131 126 108 152 431 172 265 584
2025/20262.533 586 365 1.434 148 0 0 0 0 0 0 0 0
Totale 9.007